Therapeutic effect of SN50, an inhibitor of nuclear factor-κB, in treatment of TBI in mice.
about
Resolution of Inflammation: What Controls Its Onset?Cathepsin B is a New Drug Target for Traumatic Brain Injury Therapeutics: Evidence for E64d as a Promising Lead Drug CandidateStudies of selective TNF inhibitors in the treatment of brain injury from stroke and trauma: a review of the evidence to datePhotodynamic therapy induces an immune response against a bacterial pathogenNuclear factor-kappa B influences early phase of compensatory lung growth after pneumonectomy in miceZBP-89 reduces histone deacetylase 3 by degrading IkappaB in the presence of Pin1Modulators of HIF1α and NFkB in Cancer Treatment: Is it a Rational Approach for Controlling Malignant Progression?Switching off key signaling survival molecules to switch on the resolution of inflammation.Protective effects of PARP inhibitor, PJ34, is related to down-regulation of calpain and NF-κB in a mouse model of TBI.Traumatic Brain Injury-Induced Neuronal Apoptosis is Reduced Through Modulation of PI3K and Autophagy Pathways in Mouse by FTY720.Transplantation of bone mesenchymal stem cells promotes angiogenesis and improves neurological function after traumatic brain injury in mouse.Investigation Into the Effects of Tenilsetam on Markers of Neuroinflammation in GFAP-IL6 Mice.Novel TNF receptor-1 inhibitors identified as potential therapeutic candidates for traumatic brain injury.The double stranded RNA analog poly-IC elicits both robust IFN-λ production and oncolytic activity in human gastrointestinal cancer cells
P2860
Q26747410-DE65F30D-FF60-4C85-BFB9-CF01266E0CF0Q26782938-B2BA3356-BB71-4B30-B44F-4179CBEC28DCQ27001147-238F5199-77C5-4F06-98AE-AD28492E4861Q27013274-29B6BB50-0883-4FDE-A885-50CAC30517AAQ33876856-04B7E0B3-B47F-4C8D-B1EF-5D62FF169B9FQ35030172-E1E2D810-5615-4CE5-9D39-BADD8E15DB8CQ38081415-F965EECF-568C-43FA-BFE1-0D928A70F197Q38241177-22CA9153-ADE6-4819-A0E6-D8AD97377DFAQ39817883-A1CE36B1-30FF-4467-B2DB-807958EE7D11Q40811091-4DC098FC-FFF8-4374-BF02-F6E4DB8EF617Q45498139-166ED635-ED16-469D-BC7B-770EE20ACE04Q48300482-CBBA5F77-AA09-4D1E-8665-A372C4FFA4FFQ55231012-8EE84A8E-DEDB-44AD-B0FC-8D10553C5876Q57818348-1F165D7B-FC13-4CFC-8D19-4F9DAA3B9FF7
P2860
Therapeutic effect of SN50, an inhibitor of nuclear factor-κB, in treatment of TBI in mice.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Therapeutic effect of SN50, an ...... , in treatment of TBI in mice.
@en
Therapeutic effect of SN50, an ...... , in treatment of TBI in mice.
@nl
type
label
Therapeutic effect of SN50, an ...... , in treatment of TBI in mice.
@en
Therapeutic effect of SN50, an ...... , in treatment of TBI in mice.
@nl
prefLabel
Therapeutic effect of SN50, an ...... , in treatment of TBI in mice.
@en
Therapeutic effect of SN50, an ...... , in treatment of TBI in mice.
@nl
P2093
P2860
P1476
Therapeutic effect of SN50, an ...... , in treatment of TBI in mice.
@en
P2093
Cheng-Liang Luo
Ding-Kun Dai
Hai-Jun Bao
Lu-Yang Tao
Xi-Ping Chen
Xue-Ying Feng
Yu-Xia Sun
P2860
P2888
P304
P356
10.1007/S10072-012-1007-Z
P577
2012-03-23T00:00:00Z